Financial reports
20-F
2023 FY
Annual report (foreign)
14 Feb 24
20-F
2022 FY
Annual report (foreign)
22 Feb 23
20-F
2021 FY
Annual report (foreign)
16 Feb 22
20-F
2020 FY
Annual report (foreign)
29 Mar 21
20-F
2019 FY
Annual report (foreign)
30 Mar 20
ARS
2006 FY
Annual report to shareholders
28 Apr 08
ARS
2007 FY
Annual report to shareholders
28 Apr 08
Current reports
6-K
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
16 Apr 24
6-K
Current report (foreign)
15 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
3 Apr 24
6-K
Current report (foreign)
2 Apr 24
6-K
Current report (foreign)
25 Mar 24
6-K
Current report (foreign)
21 Mar 24
6-K
Completion of share buy-back program
18 Mar 24
6-K
Genmab Announces Initiation of Share Buy-Back Program
15 Mar 24
6-K
Current report (foreign)
13 Mar 24
Registration and prospectus
S-8
Registration of securities for employees
22 Feb 24
S-8
Registration of securities for employees
24 Feb 22
S-8
Registration of securities for employees
25 Feb 21
424B4
Prospectus supplement with pricing info
19 Jul 19
F-6EF
Automatic registration for ADRs (foreign)
18 Jul 19
F-1MEF
Registration statement to add securities to prior F-1 registration
17 Jul 19
S-8
Registration of securities for employees
17 Jul 19
FWP
Free writing prospectus
16 Jul 19
F-1/A
Registration statement (foreign) (amended)
16 Jul 19
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
15 Jul 19
Proxies
No filings
Other
EFFECT
Notice of effectiveness
18 Jul 19
CERT
Certification of approval for exchange listing
15 Jul 19
CORRESP
Correspondence with SEC
12 Jul 19
CORRESP
Correspondence with SEC
12 Jul 19
SEC STAFF
SEC staff action: Order
14 Jun 19
CORRESP
Correspondence with SEC
28 May 19
UPLOAD
Letter from SEC
15 May 19
SEC STAFF
SEC staff action: Order
12 Apr 19
UPLOAD
Letter from SEC
11 Apr 19
UPLOAD
Letter from SEC
28 Feb 19
Ownership
144
Notice of proposed sale of securities
1 Mar 24
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
BlackRock Inc.
2 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
6 Feb 23
SC 13G/A
BlackRock Inc.
1 Feb 23
SC 13G/A
BlackRock Inc.
3 Feb 22
SC 13G/A
BlackRock Inc.
29 Jan 21
SC 13G
Beneficial ownership report
7 Feb 20